A panel will discuss why medical device and pharmaceutical companies are turning to wearables to improve R&D.

Omar Ford

May 31, 2022

1 Min Read
Image courtesy of vectorjuice / Alamy Stock Vector

Wearables are one of the fastest growing markets in healthcare. In 2021, the wearable technology market was valued at $116.2 billion and is anticipated to reach $265.4 billion by 2026, growing at a CAGR of 18% according to a report from ASD Reports.

During IME South a panel will discuss why "Medical Device & Pharmaceutical Companies Are Turning to Wearables to Improve R&D."

Wearables, which use a combination of a sensor and app‐based data collection, make it easier for patient data to be gathered and analyzed during the research phase.

This data provides insight into what’s happening in their body and often better helps analyze patient use, more so than the human eye can interpret. This leads to improved design of the treatment, knowing the underlying issues of the problem.

The panel will feature:

  • Mark Felice, VP Business Development & Licensing, Valencell

  • Nico O'Kuinghttons, VP, Decentralized Clinical Trials (DCT), Huma

  • Mobishar Shandhi, Postdoctoral Associate, Duke University.

Visit https://www.imengineeringsouth.com/en/show-brands/mdm-south.html to register for IME South, held June 14-16 in Charlotte, NC. The event features MD&M South, Design & Manufacturing South, ATX South, Plastec South, SouthPack, and Powder & Bulk Solids South.

About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the Design News Daily newsletter.

You May Also Like